Ergothioneine

Ergothioneine has been studied in 330 papers since 1964: 7 trials and 24 observational studies in people, 86 in animals, 119 in cells, 75 reviews; 38 in the past year. The newest paper, Nov 19, 2026: “Mitochondrial Dysfunction and Skin Aging: From Fibroblast Senescence to Disrupted ECM Homeostasis”.

Intervention

330 papers study it26 more mention it122 findingsUpdated

PubChemChEBIMeSH

Research on it is growing 40% faster than aging research as a whole: 10 papers in the latest year counted

More supplements

7 new papers in 30 daysSee all 104 papers on ergothioneine

At a glance

Independent labs found the same change in cells, worms or flies, mice and people. 28 independent labs in 16 countries; 8 trials, 3 about aging, 1 with no results posted.

“mean AMH increased from 1.81 ± 0.72 to 2.46 ± 1.54 ng/mL (mean change + 0.65 ng/mL, 95% CI [0.14, 1.17], p = 0.018)”
Oral L-ergothioneine supplementation in women with suboptimal ovarian reserve: a single-center, open-label, self-controlled pilot study of ovarian reserve markers, endocrine profiles, and reproductive aging-related symptomsBMC women's health2026doi:10.1186/s12905-026-04604-x

2 of its findings point the other way.

Cells, worms or flies, mice and humans: replicated by independent labs.
  • 28 independent labs in 16 countries
  • 2 findings against
  • 8 trials, 3 about aging, 1 with no results posted
  • Funders: National Institutes of Health and others
  • 10 of 89 findings with company ties
  • Human trial6
  • Humans11
  • Animals18
  • Model organisms3
  • Cells4

Studies in people

4 studies gave ergothioneine to people and measured what changed.

What changedDesignPeopleSource

up: Increases anti-Müllerian hormone+0.65 ng/mL (95% CI [0.14, 1.17])

down: Decreases follicle stimulating hormone-1.33 mIU/mL (95% CI [-2.50, -0.17])

up: Increases estradiol+19.69 pg/mL (95% CI [3.99, 35.38])

Trialthree consecutive menstrual cycles36 peopleWomen35-45 yearsMidlife adults; suboptimal ovarian reserveBMC women's health, Jun 17, 2026

up: Improves sleep quality

Randomized trial16 weeks100 people51 were females (26 in the EGT group and 25 in the placebo group), and 49 were males (24 in the EGT group and 25 in the placebo group)aged 40–64 yearsJapanese volunteersFood science & nutrition, Jun 5, 2025

up: Improves cognitive function

no change: Has no effect on renal and liver function markers

Randomized trialone year19 peopleaged 60 or aboveOlder adults; mild cognitive impairmentJournal of Alzheimer's disease : JAD, Nov 15, 2024

up: Increases serum EV-derived phosphorylated TrkB

Randomized trialNPJ science of food, Feb 6, 2024

What did studies of ergothioneine find?

67

Studies of ergothioneine measured 67 outcomes; the most studied are cognitive function (11 studies), inflammation (10) and oxidative stress and ROS signaling (9).

Cognitive function

upin humans4upin mice4upin reviews4

11 studies
  1. Ergothioneine improves cognitive function in humans (mild cognitive impairment).

    Human trialmild cognitive impairmentcapsule25 mg per capsuleone yearn = 19

  2. Ergothioneine improves cognitive function in older adults with mild cognitive impairment.

    Reviewin older adults with mild cognitive impairment

  3. Ergothioneine improves cognitive function.

    Review

  4. Ergothioneine improves cognitive function in humans.

    Reviewup to 25 mg/day

  5. Ergothioneine improves cognitive function.

    Review

  6. Ergothioneine improves cognitive function.

    Review

  7. Ergothioneine improves cognitive function in mice.

    Animals4 ~ 5 mg/kg/daymales

  8. Ergothioneine improves cognitive function in ERGO-deficient mice.

    Animalsin ERGO-deficient mice

  9. Ergothioneine improves cognitive function in animal models.

    Reviewin animal models

  10. Ergothioneine improves cognitive function in humans.

    ReviewERGO-containing food extract tablets

All 12

Inflammation

downin reviews5downin mice3downin rats2

10 studies
  1. Ergothioneine inhibits inflammation.

    Review

  2. Ergothioneine decreases inflammation in mice.

    Animalsin ovariectomized mice; EGT alone or combined with vitamin K2, vitamin D3 and magnesium L-threonate30 mg/kg/day12 weeksfemales

  3. Ergothioneine decreases inflammation.

    Review

  4. Ergothioneine decreases inflammation.

    Review

  5. Ergothioneine decreases inflammation in ovariectomized mice.

    Animalsin ovariectomized micebone marrow

  6. Ergothioneine decreases inflammation in mice (cystinuria mouse model).

    Animalscystinuria mouse modelkidney

  7. Ergothioneine decreases inflammation.

    Review

  8. Ergothioneine inhibits inflammation.

    Review

  9. Ergothioneine inhibits inflammation in rats (fructose-streptozotocin-induced type-2 diabetic rats).

    Animalsfructose-streptozotocin-induced type-2 diabetic ratsoralkidneyseven weeksmales

  10. Ergothioneine decreases inflammation in rats (cytokine insufflated).

    Animalscytokine insufflatedlung

More on Inflammation

Oxidative stress and ROS signaling

downin reviews5downin mice2no changein O. cuniculus1downin rats1

9 studies
  1. Ergothioneine inhibits oxidative stress and ROS signaling.

    Review

  2. Ergothioneine decreases oxidative stress and ROS signaling in ovariectomized mice.

    Animalsin ovariectomized miceserum12 weeksfemales

  3. Ergothioneine decreases oxidative stress and ROS signaling in mice.

    Animalsin ovariectomized mice; EGT alone or combined with vitamin K2, vitamin D3 and magnesium L-threonate30 mg/kg/day12 weeksfemales

  4. Ergothioneine protects against oxidative stress and ROS signaling.

    Review

  5. Ergothioneine decreases oxidative stress and ROS signaling.

    Review

  6. Ergothioneine decreases oxidative stress and ROS signaling.

    Review

  7. Ergothioneine inhibits oxidative stress and ROS signaling.

    Review

  8. Ergothioneine decreases oxidative stress and ROS signaling in low-dose mercury chloride-treated rats.

    Animalsin low-dose mercury chloride-treated ratsaorta2 μg/kg30 daysmales

  9. Ergothioneine showed no clear effect on oxidative stress and ROS signaling in O. cuniculus (upon reperfusion following ischemia).

    Animalsupon reperfusion following ischemiaheart10(-5) M and 10(-4) M

More on Oxidative stress and ROS signaling

Lifespan

upin worms4upin flies1upin human cells1upin mice1

6 studies
  1. Ergothioneine extends lifespan in worms.

    Model organisms

  2. Ergothioneine extends lifespan in worms.

    Model organisms

  3. Ergothioneine extends lifespan in worms.

    Model organisms

  4. Ergothioneine extends lifespan in mice.

    Animalsdissolved in drinking water4 ~ 5 mg/kg/daymales

  5. Ergothioneine extends lifespan in human cells (+4 ± 1 PD).

    Cells1 μM

  6. Ergothioneine extends lifespan in flies.

    Model organisms

  7. Ergothioneine extends lifespan in transgenic Caenorhabditis elegans overexpressing a human Aβ peptide.

    Model organismsin transgenic Caenorhabditis elegans overexpressing a human Aβ peptide

Neurodegenerative disease

downin reviews4

4 studies
  1. Ergothioneine prevents neurodegenerative disease (Reviewed cellular, animal, epidemiologic, and human intervention evidence).

    ReviewReviewed cellular, animal, epidemiologic, and human intervention evidence

  2. Ergothioneine protects against neurodegenerative disease.

    Review

  3. Ergothioneine prevents neurodegenerative disease.

    Review

  4. Ergothioneine protects against neurodegenerative disease.

    Review

More on Neurodegenerative disease

Oxidative phosphorylation

upin mice3

3 studies
  1. Ergothioneine improves oxidative phosphorylation in mice (calcium oxalate nephrolithiasis mouse model).

    Animalscalcium oxalate nephrolithiasis mouse modelkidney

  2. Ergothioneine increases oxidative phosphorylation in mice.

    Animals

  3. Ergothioneine increases oxidative phosphorylation in mice.

    Animals

More on Oxidative phosphorylation

Exercise performance

upin mice2upin reviews1

3 studies
  1. Ergothioneine improves exercise performance.

    Review

  2. Ergothioneine improves exercise performance in mice.

    Animals

  3. Ergothioneine improves exercise performance in mice.

    Animals

Healthspan

upin reviews1upin worms1

2 studies
  1. Ergothioneine improves healthspan in preclinical models.

    Reviewin preclinical models

  2. Ergothioneine improves healthspan in transgenic Caenorhabditis elegans overexpressing a human Aβ peptide.

    Model organismsin transgenic Caenorhabditis elegans overexpressing a human Aβ peptide

Osteoclastogenesis

downin mouse cells2

2 studies
  1. Ergothioneine inhibits osteoclastogenesis in vitro.

    Cellsin vitro

  2. Ergothioneine inhibits osteoclastogenesis in mouse cells (RANKL-induced in vitro).

    CellsRANKL-induced in vitro

Bone loss

downin mice2

2 studies
  1. Ergothioneine decreases bone loss in ovariectomized mice.

    Animalsin ovariectomized mice

  2. Ergothioneine decreases bone loss in OVX mice.

    Animalsin OVX mice

Serum EV-derived phosphorylated TrkB

upin humans1

1 study
  1. Ergothioneine increases serum EV-derived phosphorylated TrkB.

    Human trial12 weeks

  2. Ergothioneine increases serum EV-derived phosphorylated TrkB in humans.

    Human trialtabletsserum extracellular vesicles

More on Serum EV-derived phosphorylated TrkB

Pittsburgh Sleep Quality Index

downin humans1

1 study
  1. Ergothioneine decreases Pittsburgh Sleep Quality Index in humans (suboptimal ovarian reserve) (from 6.89 ± 1.82 to 5.50 ± 1.40).

    Human trialsuboptimal ovarian reserveoral120 mg/daythree consecutive menstrual cyclesfemalesn = 36

More on Pittsburgh Sleep Quality Index

Kupperman Index

downin humans1

1 study
  1. Ergothioneine decreases Kupperman Index in humans (suboptimal ovarian reserve) (from 5.42 ± 3.66 to 1.90 ± 2.16).

    Human trialsuboptimal ovarian reserveoral120 mg/daythree consecutive menstrual cyclesfemalesn = 36

More on Kupperman Index

Estradiol

upin humans1

1 study
  1. Ergothioneine increases estradiol in humans (suboptimal ovarian reserve) (+19.69 pg/mL (95% CI [3.99, 35.38])).

    Human trialsuboptimal ovarian reserveoralserum120 mg/daythree consecutive menstrual cyclesfemalesn = 36

More on Estradiol

Follicle stimulating hormone

downin humans1

1 study
  1. Ergothioneine decreases follicle stimulating hormone in humans (suboptimal ovarian reserve) (-1.33 mIU/mL (95% CI [-2.50, -0.17])).

    Human trialsuboptimal ovarian reserveoralserum120 mg/daythree consecutive menstrual cyclesfemalesn = 36

More on Follicle stimulating hormone

All 67

What is ergothioneine linked with?

5

Studies link ergothioneine with 5 measures, among them Aβ42:40 ratio, preeclampsia and neurodegenerative disease.

Aβ42:40 ratio

upin humans1

1 study
  1. Ergothioneine is associated with Aβ42:40 ratio in the Aβ+ group (r = 0.48, pFDR = 0.05).

    Humansin the Aβ+ groupn = 35

More on Aβ42:40 ratio

Preeclampsia

downin humans1

1 study
  1. Ergothioneine lowers the risk of preeclampsia in humans (higher plasma ergothioneine levels).

    Reviewhigher plasma ergothioneine levels

More on Preeclampsia

Neurodegenerative disease

downin humans1

1 study
  1. Ergothioneine lowers the risk of neurodegenerative disease in humans (restoring ET levels in the body).

    Reviewrestoring ET levels in the body

More on Neurodegenerative disease

Longevity

upin reviews1

1 study
  1. Ergothioneine is associated with longevity.

    Review

Blood ergothioneine level

downin humans1

1 study
  1. Ergothioneine is associated with blood ergothioneine level in patients.

    Reviewin patients

More on Blood ergothioneine level

What acts on ergothioneine?

1

Studies name SLC22A4 as acting on ergothioneine.

SLC22A4

upin reviews1

1 study
  1. SLC22A4 increases ergothioneine.

    Review

More on SLC22A4

Has ergothioneine been tested in people?

3 of 8 about aging

Yes: 7 trials and 24 observational studies in people have been published, and 8 trials are registered.

Every condition in trials

All 8

Trial sponsors

Funding

1 grant since 2025

Japan Society for the Promotion of Science¥4.6M

Latest

Dec 2025: 2Jan 2026: 2Feb 2026: 0Mar 2026: 5Apr 2026: 5May 2026: 2Jun 2026: 6Jul 2026: 2Aug 2026: 4Sep 2026: 2Oct 2026: 4Nov 2026: 337 papers in 12 months

See all 104 papers on ergothioneine